IDONTRAX PIK3CA enables the reliable detection of mutations in the PIK3CA gene using an optimised mix of primers and fluorescent probes, specifically designed for digital PCR (dPCR) analysis.
The test targets the main clinically relevant PIK3CA mutations, including:
exon 9 : E542K, E545K, Q546K | exon 20: H1047R, H1047L | exon 7: C420R
These alterations play a key role in therapeutic decision-making and patient monitoring in oncology.
Based on ICE* technology developed by ID SOLUTIONS, IDONTRAX PIK3CA guarantees high sensitivity and excellent reproducibility, including on challenging clinical samples such as plasma (cfDNA) or FFPE tissue (gDNA).
The reagents are supplied in pre-mixed tubes, with ready-to-use primers and probes, to simplify preparation, reduce handling and ensure optimal standardisation of results in routine laboratory settings.
*Not included in the kit.
